Aimed Alliance Urges Maryland PDAB to Protect Patient Access in UPL Deliberations
Aimed Alliance sent letters to the Maryland PDAB urging it to proceed cautiously with setting…
Author Aimed Alliance
GLOBE Model Expected to Have Minimal Impact on Part B OOP Costs
A new analysis published by Avalere Health found that the proposed GLOBE (Global Benchmark for Efficient…
New Report – International Reference Pricing: Lessons Learned from Abroad
For decades, rising costs of health care, health insurance, and prescription drugs have been a…
Aimed Alliance Urges Reconsideration of VA PDAB Bill
Aimed Alliance recently sent a letter urging the Virginia House Labor and Commerce Committee to…
CDC Updates U.S. Childhood Immunization Schedule
On January 5, the Centers for Disease Control and Prevention (CDC) Acting Director Jim O’Neill…
Aimed Alliance Publishes Updated 2025 PDAB Resources
Aimed Alliance is pleased to share two new resources on prescription drug affordability boards (PDABs).…
Aimed Alliance Published 2025 Gold Card Recap Resource
Gold card laws exempt healthcare providers from prior authorization if they have a high approval…
Congress Unveils SAFE Drugs Act to Address Risks of Compounded Medications
On December 10, 2025, Representatives Rudy Yakym (R-IN) and André Carson (D-IN) introduced the Safeguarding…
New Resource Helps Policymakers Protect Consumers from Deceptive AFPs
Aimed Alliance, the National Bleeding Disorders Foundation and the Hemophilia Alliance, released a new resource,…
Trump Administration Must Address the Use of Junk Science
On December 5, 2025, Aimed Alliance’s Counsel, Michael Barnes, published a new opinion piece titled…